CXCR2 and neoplasm: CXCR2 (CXC chemokine receptor 2) is inhibited by blocking the recruitment of pro-tumour neutrophils to the TME, which blocks activation signals such as G-CSF or TNFα and ROS production by inhibiting contact with T cells (49, 52).